Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone Dose-Finding in Endometriosis
NCT02271958Phase 3Completed
- Sponsor
- Mediterranea Medica
- Start
- Nov 2010
- Primary completion
- Oct 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of mifepristone in endometriosis (4 arms), sponsored by Mediterranea Medica. Primary endpoints: Changes in prevalence of dysmenorrhea and the average reduction in its intensity at 6 months, Incidence of hot flushes, nausea, dizzy spells, vomiting, fatigue/tiredness, raised hepatic transaminases, histological alterations of the endometrium at 6 months and 1 more. Started Nov 2010; status: completed.
02
Drugs
mifepristone
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT02271958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02271958.